中國新城鎮(01278.HK)擬向合營企業注資5250萬元
格隆匯5月18日丨中國新城鎮(01278.HK)發佈公吿,2022年5月18日,公司間接全資附屬公司國錫南京、江蘇省建一公司與合營企業(即南京國英中西建設開發有限公司)訂立注資協議,據此,合營企業的註冊股本將由人民幣2.20億元增至3.25億元;國錫南京同意通過資本化2018年國錫南京借款及2020年國錫南京借款的方式向合營企業增加資本金人民幣5250萬元;及江蘇省建一公司同意通過資本化2020年江蘇省建借款及2021年江蘇省建借款的方式向合營企業增加資本金人民幣5250萬元。
緊接注資前,合營企業分別由國錫南京及江蘇省建一公司擁有50%及50%的股權。國錫南京及江蘇省建一公司根據注資協議完成按比例注資後,國錫南京及江蘇省建一公司於合營企業的股權將維持不變。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.